Perioperative systemic treatments in renal cell carcinoma

被引：3
作者：
Goswamy, Rohit [1 ,2 ]
Kalemoglu, Ecem [3 ]
Master, Viraj [2 ,4 ]
Bilen, Mehmet Asim [1 ,2 ]
机构：
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA USA
[4] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
renal cell carcinoma; neoadjuvant; adjuvant; kidney cancer; review; cancer; RCC (Renal Cell Carcinoma); outcomes; NIVOLUMAB PLUS CABOZANTINIB; HIGH-RISK; INTERFERON-ALPHA; PHASE-III; FOLLOW-UP; NEOADJUVANT AXITINIB; SURGICAL-MANAGEMENT; ADJUVANT PAZOPANIB; SURVIVAL ANALYSIS; DOUBLE-BLIND;
D O I：
10.3389/fonc.2024.1362172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this review, we aim to provide a comprehensive assessment of the evolving landscape of the perioperative management in renal cell carcinoma (RCC), emphasizing its dynamic and intricate nature. We explore academic and clinical insights into the perioperative treatment paradigm of RCC. Up-to-date treatment options are discussed and the evolving role of neoadjuvant and adjuvant therapy in RCC is highlighted.
引用
收藏
页数：15
相关论文
共 88 条
  • [41] Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
    Haas, Naomi B.
    Manola, Judith
    Uzzo, Robert G.
    Flaherty, Keith T.
    Wood, Christopher G.
    Kane, Christopher
    Jewett, Michael
    Dutcher, Janice P.
    Atkins, Michael B.
    Pins, Michael
    Wilding, George
    Cella, David
    Wagner, Lynne
    Matin, Surena
    Kuzel, Timothy M.
    Sexton, Wade J.
    Wong, Yu-Ning
    Choueiri, Toni K.
    Pili, Roberto
    Puzanov, Igor
    Kohli, Manish
    Stadler, Walter
    Carducci, Michael
    Coomes, Robert
    DiPaola, Robert S.
    [J]. LANCET, 2016, 387 (10032) : 2008 - 2016
  • [42] Hannan R., ClinicalTrials.Gov
  • [43] SURGICAL-MANAGEMENT AND PROGNOSIS OF RENAL-CELL CARCINOMA INVADING THE VENA-CAVA
    HATCHER, PA
    ANDERSON, EE
    PAULSON, DF
    CARSON, CC
    ROBERTSON, JE
    [J]. JOURNAL OF UROLOGY, 1991, 145 (01) : 20 - 24
  • [44] Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma
    Hatiboglu, Gencay
    Hohenfellner, Markus
    Arslan, Aysenur
    Hadaschik, Boris
    Teber, Dogu
    Radtke, Jan Philipp
    Hallscheidt, Peter
    Tolstov, Yanis
    Roth, Wilfried
    Gruelich, Carsten
    Huesing, Johannes
    Duensing, Stefan
    Pahernik, Sascha
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2017, 402 (04) : 637 - 644
  • [45] Rising incidence of small renal masses: A need to reassess treatment effect
    Hollingsworth, John M.
    Miller, David C.
    Daignault, Stephanie
    Hollenbeck, Brent K.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (18): : 1331 - 1334
  • [46] Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy With Perioperative Outcomes and Health Care Costs, 2003 to 2015
    Jeong, In Gab
    Khandwala, Yash S.
    Kim, Jae Heon
    Han, Deok Hyun
    Li, Shufeng
    Wang, Ye
    Chang, Steven L.
    Chung, Benjamin I.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (16): : 1561 - 1568
  • [47] Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
    Karam, Jose A.
    Devine, Catherine E.
    Urbauer, Diana L.
    Lozano, Marisa
    Maity, Tapati
    Ahrar, Kamran
    Tamboli, Pheroze
    Tannir, Nizar M.
    Wood, Christopher G.
    [J]. EUROPEAN UROLOGY, 2014, 66 (05) : 874 - 880
  • [48] Surgery Insight: management of renal cell carcinoma with associated inferior vena cava thrombus
    Karnes, R. Jeffrey
    Blute, Michael L.
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (06): : 329 - 339
  • [49] The RENAL Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
    Kutikov, Alexander
    Uzzo, Robert G.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (03) : 844 - 853
  • [50] Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study
    Lebacle, Cedric
    Bensalah, Karim
    Bernhard, Jean-Christophe
    Albiges, Laurence
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Baumert, Herve
    Lang, Herve
    Tricard, Thibault
    Duclos, Brigitte
    Arnoux, Armelle
    Piedvache, Celine
    Patard, Jean-Jacques
    Escudier, Bernard
    [J]. BJU INTERNATIONAL, 2019, 123 (05) : 804 - 810
123456789